SMOC1 and skin reaction: As this isoform has been described as less allergenic than Mal d 1.01,38 we performed competitive ELISA with recombinant Mal d 1.0108 known to induce dose‐dependent skin reactions and OAS in individuals with BPRAA.39, 40, 41